The firm owned 71,297 shares of the aerospace company’s stock after buying an additional 15,763 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in CAE were worth ...

The Government has issued a Resolution on approving a program for cutting and simplifying administrative procedures related ...

Research analysts at Roth Capital cut their Q1 2025 earnings estimates for Fathom in a note issued to investors on Thursday, March 13th. Roth Capital analyst D. Aftahi now forecasts that the company ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant ...

Source: Xeris Biopharma Holdings, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative ...